Many patients have drug therapy problems AFTER they start therapy, not before. The therapy isn’t working, it is causing side effects, or the patient isn’t taking it as prescribed. Or…everything is great. Assessing existing therapy is one of the most important roles of pharmacists, whether it’s renewals, med reviews, chronic disease management or checking in on a refill. The podcast series, 2 Cs 2 As (Control (Efficacy), Complications, Adherence, Adverse Effects), will look at ways to assess various treatments and conditions to support pharmacists in their care for patients and documentation.

PANS' Glenn Rodrigues and Dan Rainkie, Assistant Professor at Dalhousie University's College of Pharmacy, talk in depth about Rheumatoid Arthritis and how pharmacists can evaluate treatment efficacy, what type of red flags to look out for and what a pharmacist can reasonably assess on their own, within their scope.

Daniel Rainkie is an Assistant Professor at Dalhousie University's College of Pharmacy. Daniel received a Shoppers Drug Mart Research Grant in April 2024 and recently presented on this topic at the 2024 Nova Scotia Pharmacy Conference. Daniel has no other declarations and conflict(s) of interest.

DO YOU CURRENTLY LIVE AND/OR PRACTICE PHARMACY IN NOVA SCOTIA? BECOME A PANS MEMBER AND RECEIVE CEUs FOR LISTENING TO THIS EPISODE!

Copyright Notice

By accessing the PANS Pods and PANS Podcast (the “Podcast”) you acknowledge that the contents, design, and materials are the property of the Pharmacy Association of Nova Scotia (PANS) or used by PANS with permission. The Podcast and its data, content, information, and other materials are protected under Canadian copyright and trademark laws. The Podcast is for general educational purposes only. No other use, including, without limitation, reproduction, retransmission, or editing, may be made without the prior written permission of PANS.

Disclaimer

The Podcast and content contained therein, including text, images, audio, or other formats, were created for general education and informational purposes only. The content is not intended to be a substitute for professional medical advice, clinical diagnosis, or treatment. Reliance on any information provided is solely at your own risk. Furthermore, any third-party materials or content of any third-party site referenced in the Podcast do not necessarily reflect the opinions, standards, or policies of PANS. PANS assumes no responsibility or liability for the accuracy or completeness of the content of guests or contained in third-party materials or on third-party sites referenced in this Podcast or the compliance with applicable laws of such materials and/or links referenced therein.

Limitation of Liability

PANS EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR OTHER DAMAGES, INCLUDING WITHOUT LIMITATION LOSS OF PROFITS, ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PRODUCTS OR THE INFORMATION PRESENTED IN THE PODCASTS.